PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsEiger Biopharmaceuticals
Eiger Biopharmaceuticals(EIGR)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ZokinvyLonafarnib2022-07-182023-2024
Progeria
,
Laminopathies
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lonafarnib
chronic hepatitis
,
progeria
,
chronic hepatitis d
,
hepatitis d
,
hepatitis
,
virus diseases
,
hepatitis a
,
laminopathies
Alfacalcidol
erectile dysfunction
Avexitide
bariatric surgery
,
healthy volunteers/patients
,
hyperglycemia
,
nutrition disorders
,
gastric emptying
,
digestive system physiological phenomena
,
gastrointestinal motility
,
diabetes mellitus
,
congenital hyperinsulinism
,
nesidioblastosis
,
hyperinsulinism
,
dyspepsia
,
hypoglycemia
,
type 2 diabetes mellitus
,
obesity
,
insulin secretion
,
prediabetic state
,
glucose metabolism disorders
,
metabolic diseases
,
kidney diseases
,
stomach neoplasms
,
dumping syndrome
,
morbid obesity
,
heart diseases
,
exploratory behavior
,
appetite regulation
Sodium chloride
graft rejection
Clemizole
hepatitis c
,
hepatitis
,
hepatitis a
,
colorectal neoplasms
,
colonic polyps
,
adenomatous polyps
,
myoclonic epilepsies
,
depression
,
major depressive disorder
,
depressive disorder
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
immunoglobulin light-chain amyloidosis
,
amyloidosis
,
syndrome
,
fever
,
lennox gastaut syndrome
,
malaria
,
falciparum malaria
,
post-traumatic stress disorders
,
traumatic stress disorders
,
neoplasms
,
lung neoplasms
,
eye abnormalities
,
bone marrow examination
Nepidermin
carcinoma
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
neoplasms
,
colorectal neoplasms
,
breast neoplasms
,
ovarian neoplasms
,
pancreatic ductal carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
adenocarcinoma
,
squamous cell carcinoma
,
biliary tract neoplasms
,
esophageal squamous cell carcinoma
,
ovarian epithelial carcinoma
,
glioblastoma
,
non-small-cell lung carcinoma
,
gliosarcoma
,
lung neoplasms
Ubenimex
hypertension
,
pulmonary arterial hypertension
,
familial primary pulmonary hypertension
,
lymphedema
,
ischemic stroke
,
stroke
,
ischemia
,
chronic obstructive pulmonary disease
Fendrix
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
Ebp921
hepatitis d
,
hepatitis
,
hepatitis a
Mevalotin
drug interactions
,
hyperlipidemias
,
hyperlipoproteinemia type iii
,
hyperlipoproteinemias
,
hypercholesterolemia
Exendin9
healthy volunteers/patients
,
bariatric surgery
,
hyperglycemia
,
nutrition disorders
,
gastric emptying
,
digestive system physiological phenomena
,
gastrointestinal motility
,
gastric bypass
,
gastrectomy
,
congenital hyperinsulinism
,
nesidioblastosis
,
hyperinsulinism
,
dyspepsia
,
hypoglycemia
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
insulin secretion
,
prediabetic state
,
glucose metabolism disorders
,
metabolic diseases
,
kidney diseases
,
stomach neoplasms
,
dumping syndrome
,
morbid obesity
,
heart diseases
,
exploratory behavior
,
appetite regulation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use